Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 33 Records) |
| Query Trace: Liver Diseases and TM6SF2[original query] |
|---|
| The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP). Liver international : official journal of the International Association for the Study of the Liver 2015 Aug . Arslanow Anita, Stokes Caroline S, Weber Susanne N, Grünhage Frank, Lammert Frank, Krawczyk Marc |
| Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study. Hepatology (Baltimore, Md.) 2015 Oct . Goffredo Martina, Caprio Sonia, Feldstein Ariel E, D'Adamo Ebe, Shaw Melissa M, Pierpont Bridget, Savoye Mary, Zhao Hongyu, Bale Allen E, Santoro Nico |
| Childhood predictors of adult fatty liver. The Cardiovascular Risk in Young Finns Study. Journal of hepatology 2016 May . Suomela Emmi, Oikonen Mervi, Pitkänen Niina, Ahola-Olli Ari, Virtanen Johanna, Parkkola Riitta, Jokinen Eero, Laitinen Tomi, Hutri-Kähönen Nina, Kähönen Mika, Lehtimäki Terho, Taittonen Leena, Tossavainen Päivi, Jula Antti, Loo Britt-Marie, Mikkilä Vera, Telama Risto, Viikari Jorma S A, Juonala Markus, Raitakari Olli |
| TM6SF2 rs58542926 impacts lipid processing in liver and small intestine. Hepatology (Baltimore, Md.) 2016 12 65 (5): 1526-1542. O'Hare Elizabeth A, Yang Rongze, Yerges-Armstrong Laura M, Sreenivasan Urmila, McFarland Rebecca, Leitch Carmen C, Wilson Meredith H, Narina Shilpa, Gorden Alexis, Ryan Kathy A, Shuldiner Alan R, Farber Steve A, Wood G Craig, Still Christopher D, Gerhard Glenn S, Robishaw Janet D, Sztalryd Carole, Zaghloul Norann |
| PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC. PloS one 2018 13 (8): e0202942. Kruk Beata, Liebe Roman, Milkiewicz Ma?gorzata, Wunsch Ewa, Raszeja-Wyszomirska Joanna, Lammert Frank, Milkiewicz Piotr, Krawczyk Marc |
| Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort. Hepatology (Baltimore, Md.) 2018 Apr . Tricò Domenico, Caprio Sonia, Rosaria Umano Giuseppina, Pierpont Bridget, Nouws Jessica, Galderisi Alfonso, Kim Grace, Mata Mariana M, Santoro Nico |
| PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases. International journal of cancer 2018 Oct . Yang Jie, Trépo Eric, Nahon Pierre, Cao Qian, Moreno Christophe, Letouzé Eric, Imbeaud Sandrine, Gustot Thierry, Deviere Jacques, Debette Stéphanie, Amouyel Philippe, Bioulac-Sage Paulette, Calderaro Julien, Ganne-Carrié Nathalie, Laurent Alexis, Blanc Jean Frédéric, Guyot Erwan, Sutton Angela, Ziol Marianne, Zucman-Rossi Jessica, Nault Jean-Charl |
| High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant. Hepatology (Baltimore, Md.) 2019 Jun . Gellert-Kristensen Helene, Nordestgaard Børge Grønne, Tybjaerg-Hansen Anne, Stender Stef |
| Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility. Clinics and research in hepatology and gastroenterology 2019 Feb . Xia Yan, Huang Chun-Xia, Li Guang-Yi, Chen Kai-Hua, Han Li, Tang Liang, Luo Huai-Qing, Bao Mei-H |
| Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis. Seminars in liver disease 2019 Mar . Fujiwara Naoto, Hoshida Yuj |
| Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography. Hepatology (Baltimore, Md.) 2019 Mar . Caussy Cyrielle, Bhargava Meera, Villesen Ida F, Gudmann Natasja S, Leeming Diana J, Karsdal Morten A, Faulkner Claire, Bao Denny, Liu Amy, Lo Min-Tzu, Bettencourt Ricki, Bassirian Shirin, Richards Lisa, Brenner David A, Chen Chi-Hua, Sirlin Claude B, Loomba Roh |
| Risk of chemotherapy-associated liver injury (CALI) in PNPLA3 p.148M allele carriers: Preliminary results of a transient elastography-based study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019 Oct . Casper Markus, Zimmermann Simone, Weber Susanne N, Arslanow Anita, Lammert Frank, Krawczyk Marc |
Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors.
Hepatology (Baltimore, Md.) 2020 Aug . Schwantes-An Tae-Hwi, Darlay Rebecca, Mathurin Philippe, Masson Steven, Liangpunsakul Suthat, Mueller Sebastian, Aithal Guruprasad P, Eyer Florian, Gleeson Dermot, Thompson Andrew, Muellhaupt Beat, Stickel Felix, Soyka Michael, Goldman David, Liang Tiebing, Lumeng Lawrence, Pirmohamed Munir, Nalpas Bertrand, Jacquet Jean-Marc, Moirand Romain, Nahon Pierre, Naveau Sylvie, Perney Pascal, Botwin Greg, Haber Paul S, Seitz Helmut K, Day Christopher P, Foroud Tatiana M, Daly Ann K, Cordell Heather J, Whitfield John B, Morgan Timothy R, Seth Devanshi, |
| Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD. Hepatology communications 2020 5 4 (5): 670-680. Ezaz Ghideon, Trivedi Hirsh D, Connelly Margery A, Filozof Claudia, Howard Kellie, L Parrish Mark, Kim Misung, Herman Mark A, Nasser Imad, Afdhal Nezam H, Jiang Z Gordon, Lai Michel |
| Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population. Hepatology (Baltimore, Md.) 2020 3 72 (3): 845-856. Gellert-Kristensen Helene, Richardson Tom G, Davey Smith George, Nordestgaard Børge G, Tybjaerg-Hansen Anne, Stender Stef |
| Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort. Hepatology communications 2021 Jun . Wang Jun, Conti David V, Bogumil David, Sheng Xin, Noureddin Mazen, Wilkens Lynne R, Le Marchand Loic, Rosen Hugo R, Haiman Christopher A, Setiawan Veronica Wen |
| Genome-Wide Association Study of NAFLD Using Electronic Health Records.
Hepatology communications 2021 Sep . Fairfield Cameron J, Drake Thomas M, Pius Riinu, Bretherick Andrew D, Campbell Archie, Clark David W, Fallowfield Jonathan A, Hayward Caroline, Henderson Neil C, Joshi Peter K, Mills Nicholas L, Porteous David J, Ramachandran Prakash, Semple Robert K, Shaw Catherine A, Sudlow Cathie L M, Timmers Paul R H J, Wilson James F, Wigmore Stephen J, Harrison Ewen M, Spiliopoulou Athi |
| Heterozygosity of the Alpha 1-Antitrypsin Pi*Z Allele and Risk of Liver Disease. Hepatology communications 2021 8 5 (8): 1348-1361. Hakim Aaron, Moll Matthew, Qiao Dandi, Liu Jiangyuan, Lasky-Su Jessica A, Silverman Edwin K, Vilarinho Silvia, Jiang Gordon Z, Hobbs Brian D, Cho Michael |
| Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis. Alcoholism, clinical and experimental research 2021 Feb . Beaudoin James J, Liang Tiebing, Tang Qing, Banini Bubu A, Shah Vijay H, Sanyal Arun J, Chalasani Naga P, Gawrieh Sam |
| The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis. Hepatology communications 2021 12 6 (5): 1213-1226. Innes Hamish, Nischalke Hans Dieter, Guha Indra Neil, Weiss Karl Heinz, Irving Will, Gotthardt Daniel, Barnes Eleanor, Fischer Janett, Ansari M Azim, Rosendahl Jonas, Lin Shang-Kuan, Marot Astrid, Pedergnana Vincent, Casper Markus, Benselin Jennifer, Lammert Frank, McLauchlan John, Lutz Philip L, Hamill Victoria, Mueller Sebastian, Morling Joanne R, Semmler Georg, Eyer Florian, von Felden Johann, Link Alexander, Vogel Arndt, Marquardt Jens U, Sulk Stefan, Trebicka Jonel, Valenti Luca, Datz Christian, Reiberger Thomas, Schafmayer Clemens, Berg Thomas, Deltenre Pierre, Hampe Jochen, Stickel Felix, Buch Steph |
| Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatology communications 2021 10 6 (3): 535-549. Meroni Marica, Longo Miriam, Lombardi Rosa, Paolini Erika, Macchi Chiara, Corsini Alberto, Sirtori Cesare R, Fracanzani Anna Ludovica, Ruscica Massimiliano, Dongiovanni Pao |
| The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 1 20 (4): e855-e875. Liu Zhenqiu, Suo Chen, Shi Oumin, Lin Chunqing, Zhao Renjia, Yuan Huangbo, Jin Li, Zhang Tiejun, Chen Xingdo |
| Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children. Hepatology (Baltimore, Md.) 2022 5 77 (1): 197-212. Goyal Nidhi P, Rosenthal Sara B, Nasamran Chanod, Behling Cynthia A, Angeles Jorge E, Fishbein Mark H, Harlow Kathryn E, Jain Ajay K, Molleston Jean P, Newton Kimberly P, Ugalde-Nicalo Patricia, Xanthankos Stavra A, Yates Katherine, Schork Nicholas J, Fisch Kathleen M, Schwimmer Jeffrey B, |
| Molecular Screening via Sanger Sequencing of the Genetic Variants in Non-Alcoholic Fatty Liver Disease Subjects in the Saudi Population: A Hospital-Based Study. Metabolites 2022 12 12 (12): . Alsaif Faisal, Al-Hamoudi Waleed, Alotaiby Maram, Alsadoon Amani, Almayouf Mohammed, Almadany Hadeel, Abuhaimed Jawahir, Ghufran Noman, Merajuddin Ahmed, Ali Khan Imr |
| MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery. International journal of molecular sciences 2022 12 23 (24): . Kalinowski Piotr, Smyk Wiktor, Nowosad Ma?gorzata, Paluszkiewicz Rafa?, Micha?owski ?ukasz, Ziarkiewicz-Wróblewska Bogna, Weber Susanne N, Milkiewicz Piotr, Lammert Frank, Zieniewicz Krzysztof, Krawczyk Marc |
| Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease. Liver international : official journal of the International Association for the Study of the Liver 2023 11 . Deepika Suresh, Ashley Li, Matthew J Miller, Karn Wijarnpreecha, Vincent L Ch |
| Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B? Journal of gastrointestinal and liver diseases : JGLD 2024 6 33 (2): 203-211. Coskun Ozer Demirtas, Fatih Eren, Demet Yilmaz, Osman Cavit Ozdogan, Feyza Gund |
| The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 2024 6 . Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Rohit Loomba, Veeral Ajme |
| Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. Clinics and research in hepatology and gastroenterology 2024 6 48 (7): 102389. Elias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, Mira Thing, Puria Nabilou, Nina Kimer, Anders Ellekaer Junker, Anne-Sofie Houlberg Jensen, Børge Grønne Nordestgaard, Stefan Stender, Lise Lotte Glu |
| PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis. Hepatology communications 2024 5 8 (6): . Esteban Urias, Nicholas R Tedesco, Daniel A Burkholder, Isabel J Moran, Matthew J Miller, Venkata Sai J Jasty, Snehal Patil, Sebastian Zoellner, Karn Wijarnpreecha, Vincent L Ch |
- Page last reviewed:Feb 1, 2024
- Content source: